Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-04
DOI
10.3389/fimmu.2019.01278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptides for optical medical imaging and steps towards therapy
- (2018) Matteo Staderini et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Monoclonal antibodies against metzincin targets
- (2018) Salvatore Santamaria et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis
- (2018) David L. Gossage et al. CLINICAL THERAPEUTICS
- Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease
- (2018) William J Sandborn et al. Journal of Crohns & Colitis
- Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
- (2018) Ahmed M.E. Abdalla et al. Theranostics
- Piezo1 mediates angiogenesis through activation of MT1-MMP signaling
- (2018) Hojin Kang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Radiosynthesis and Preliminary Biological Evaluation of 18F-Fluoropropionyl-Chlorotoxin as a Potential PET Tracer for Glioma Imaging
- (2018) Jing Zhao et al. Contrast Media & Molecular Imaging
- MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors
- (2018) Vladi Juric et al. PLoS One
- Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors
- (2018) Gadi Cohen et al. Toxins
- Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9
- (2017) Todd C. Appleby et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
- (2017) Robert H. Scannevin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases
- (2017) Manishabrata Bhowmick et al. JOURNAL OF MEDICINAL CHEMISTRY
- Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy
- (2017) Biagio Ricciuti et al. SEMINARS IN CANCER BIOLOGY
- A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models
- (2017) Binbing Ling et al. Oncotarget
- Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
- (2016) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal Excretion of Orally Administered Collagen-Like Peptides in Rats: Contribution of the Triple-Helical Conformation to Their Stability
- (2016) Takaki Koide et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality
- (2016) Dalit Talmi-Frank et al. Cell Host & Microbe
- Glioblastoma multiforme targeted therapy: The Chlorotoxin story
- (2016) Or Cohen-Inbar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis
- (2016) Jing Yu et al. Journal of Hematology & Oncology
- Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
- (2016) B. Gru nwald et al. MOLECULAR CANCER RESEARCH
- Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study
- (2016) A. Winer et al. MOLECULAR CANCER THERAPEUTICS
- The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination
- (2016) Charles Marusak et al. PHARMACOLOGICAL RESEARCH
- Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
- (2016) Dong Hyun Nam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization
- (2016) Dong Hyun Nam et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis
- (2016) Albert G. Remacle et al. Oncotarget
- Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo
- (2016) Kenneth A. Botkjaer et al. Oncotarget
- Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury
- (2015) Mijoon Lee et al. ACS Chemical Neuroscience
- Matrix Metalloproteinase Inhibition by Heterotrimeric Triple-Helical Peptide Transition State Analogues
- (2015) Manishabrata Bhowmick et al. CHEMBIOCHEM
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody
- (2015) Yael Udi et al. STRUCTURE
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
- (2015) Derek C. Marshall et al. PLoS One
- The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3
- (2014) Chao Qin et al. BIOMATERIALS
- Peptide internalization enabled by folding: triple helical cell-penetrating peptides
- (2014) Aparna Shinde et al. JOURNAL OF PEPTIDE SCIENCE
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Collagen-like Cell-Penetrating Peptides
- (2013) Chisato M. Yamazaki et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Potential of collagen-like triple helical peptides as drug carriers: Their in vivo distribution, metabolism, and excretion profiles in rodents
- (2013) Hiroyuki Yasui et al. BIOPOLYMERS
- MT-LOOP-dependent Localization of Membrane Type I Matrix Metalloproteinase (MT1-MMP) to the Cell Adhesion Complexes Promotes Cancer Cell Invasion
- (2013) Anna M. Woskowicz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP
- (2013) Signe Ingvarsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma
- (2013) R. Gyanchandani et al. MOLECULAR CANCER RESEARCH
- A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP
- (2013) S A Shiryaev et al. Oncogenesis
- Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth
- (2012) A. G. Remacle et al. CANCER RESEARCH
- Matrix Metalloproteinase Control of Capillary Morphogenesis
- (2012) Cyrus M. Ghajar et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Synthesis of Fmoc-Gly-Ile Phosphinic Pseudodipeptide: Residue Specific Conditions for Construction of Matrix Metalloproteinase Inhibitor Building Blocks
- (2012) Manishabrata Bhowmick et al. International Journal of Peptide Research and Therapeutics
- Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1
- (2012) S. W. Manka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
- (2011) Erin M. Bekes et al. AMERICAN JOURNAL OF PATHOLOGY
- Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
- (2011) A. Dufour et al. CANCER RESEARCH
- Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain
- (2011) B. Basu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Selective Water-Soluble Gelatinase Inhibitor Prodrugs
- (2011) Major Gooyit et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for Matrix Metalloproteinase 1-Catalyzed Collagenolysis
- (2011) Ivano Bertini et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential
- (2011) Netta Sela-Passwell et al. NATURE MEDICINE
- Angiogenesis
- (2011) D. R. Senger et al. Cold Spring Harbor Perspectives in Biology
- MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis
- (2011) Nor Eddine Sounni et al. Frontiers in Pharmacology
- An Autocrine Linkage Between Matrix Metalloproteinase-14 and Tie-2 Via Ectodomain Shedding Modulates Angiopoietin-1–Dependent Function in Endothelial Cells
- (2010) Mitsuho Onimaru et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors
- (2010) Manishabrata Bhowmick et al. BIOPOLYMERS
- Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events
- (2010) A. Sacharidou et al. BLOOD
- Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
- (2010) Jin Li et al. BMC CANCER
- Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time?
- (2010) Stanley Zucker et al. CANCER BIOLOGY & THERAPY
- A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth
- (2010) Juho Suojanen et al. CANCER BIOLOGY & THERAPY
- Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
- (2010) L. J. A. C. Hawinkels et al. CANCER RESEARCH
- Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease
- (2010) Daniel P. Becker et al. JOURNAL OF MEDICINAL CHEMISTRY
- The β1-Integrin–Dependent Function of RECK in Physiologic and Tumor Angiogenesis
- (2010) Takao Miki et al. MOLECULAR CANCER RESEARCH
- Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis
- (2009) A. C. Aplin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
- (2009) Elena I. Deryugina et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?
- (2009) Netta Sela-Passwell et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices
- (2009) A. N. Stratman et al. BLOOD
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- Active Site Ring-Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
- (2009) Christopher Forbes et al. Chemical Biology & Drug Design
- Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2-(1-(4-Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1-MMP Inhibitors
- (2009) Major Gooyit et al. Chemical Biology & Drug Design
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity
- (2009) Janelle L. Lauer-Fields et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activationin Vivoand Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway
- (2009) Veronica C. Ardi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast Cancer In vivo
- (2008) C. Bendrik et al. CANCER RESEARCH
- Metabolism of (4-Phenoxyphenylsulfonyl)methylthiirane, a Selective Gelatinase Inhibitor
- (2008) Giuseppe Celenza et al. Chemical Biology & Drug Design
- Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold
- (2008) Chia-Yu Fan et al. FASEB JOURNAL
- Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
- (2008) Janelle L. Lauer-Fields et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started